Squarepoint’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$587K Buy
161,192
+116,149
+258% +$423K ﹤0.01% 1820
2025
Q1
$86.5K Buy
+45,043
New +$86.5K ﹤0.01% 2550
2024
Q4
Sell
-140,167
Closed -$185K 2744
2024
Q3
$185K Buy
140,167
+101,612
+264% +$134K ﹤0.01% 2197
2024
Q2
$39.3K Sell
38,555
-216,109
-85% -$220K ﹤0.01% 2392
2024
Q1
$466K Buy
254,664
+224,108
+733% +$410K ﹤0.01% 1706
2023
Q4
$37.9K Buy
+30,556
New +$37.9K ﹤0.01% 2388
2022
Q3
Sell
-29,471
Closed -$10K 2039
2022
Q2
$10K Sell
29,471
-28,825
-49% -$9.78K ﹤0.01% 2040
2022
Q1
$42K Buy
58,296
+32,044
+122% +$23.1K ﹤0.01% 2110
2021
Q4
$59K Buy
+26,252
New +$59K ﹤0.01% 2393
2021
Q2
Sell
-238,876
Closed -$809K 2577
2021
Q1
$809K Sell
238,876
-179,904
-43% -$609K ﹤0.01% 1225
2020
Q4
$1.17M Sell
418,780
-606,616
-59% -$1.7M 0.01% 978
2020
Q3
$2.57M Buy
1,025,396
+931,780
+995% +$2.34M 0.03% 540
2020
Q2
$1.27M Sell
93,616
-127,493
-58% -$1.73M 0.02% 807
2020
Q1
$1.68M Buy
221,109
+107,989
+95% +$819K 0.04% 504
2019
Q4
$715K Sell
113,120
-53,404
-32% -$338K ﹤0.01% 1515
2019
Q3
$653K Sell
166,524
-118,521
-42% -$465K 0.01% 1432
2019
Q2
$1.38M Buy
285,045
+174,503
+158% +$845K 0.01% 1054
2019
Q1
$905K Sell
110,542
-47,463
-30% -$389K 0.01% 1149
2018
Q4
$874K Buy
158,005
+73,142
+86% +$405K 0.01% 967
2018
Q3
$749K Buy
84,863
+4,683
+6% +$41.3K 0.01% 1122
2018
Q2
$800K Buy
80,180
+28,380
+55% +$283K 0.01% 979
2018
Q1
$494K Buy
51,800
+13,996
+37% +$133K 0.01% 1091
2017
Q4
$562K Buy
+37,804
New +$562K 0.01% 1129
2017
Q1
Sell
-18,462
Closed -$192K 1488
2016
Q4
$192K Buy
+18,462
New +$192K 0.01% 1457